Eliem Therapeutics Inc
Biotechnology
Healthcare
ELYM
26.84 M shares
NASDAQ US
traded
02 Jan 2024
listed
no
open
2.70
52 week high
4.64
high
2.89
52 week low
2.30
previous Close
2.70
P/E ratio
market cap
73.96 M
div yield
0
net incoming
-5.22 M
0.00 %
net profit margin
-522000000.00 %
0.00 %
operating incoming
-6.71 M
0.00 %
net change in cash
0.00 %
cash on hand
25.29 M
0.00 %
top